✦ LIBER ✦
167 ORAL The XPD lys751gln polymorphism in colorectal cancer patients treated in first line chemotherapy with 5-FU-oxaliplatin or 5-FU-irinotecan combinations: a prognostic factor or a predictive marker of oxaliplatin efficiency?
- Book ID
- 118622747
- Publisher
- Elsevier Science
- Year
- 2005
- Tongue
- English
- Weight
- 172 KB
- Volume
- 3
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.